发明名称 Diagnosis of macrophage mediated disease
摘要 The invention relates to a method of treating or monitoring/diagnosing a disease state mediated by activated macrophages. The method comprises the step of administering to a patient suffering from a macrophage mediated disease state an effective amount of a composition comprising a conjugate or complex of the general formula <?in-line-formulae description="In-line Formulae" end="lead"?>A<SUB>b</SUB>-X <?in-line-formulae description="In-line Formulae" end="tail"?> where the group A<SUB>b </SUB>comprises a ligand capable of binding to activated macrophages, and when the conjugate is being used for treatment of the disease state, the group X comprises an immunogen, a cytotoxin, or a compound capable of altering macrophage function, and when the conjugate is being used for monitoring/diagnosing the disease state, X comprises an imaging agent. The method is useful for treating a patient suffering from a disease selected from the group consisting of rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis.
申请公布号 US2007231266(A1) 申请公布日期 2007.10.04
申请号 US20060648223 申请日期 2006.12.29
申请人 发明人 LOW PHILIP S.;TURK MARY J.
分类号 A61K51/00;G01R33/28;A61B5/055;A61K9/127;A61K39/00;A61K39/385;A61K39/395;A61K45/00;A61K47/48;A61K49/00;A61K51/10;A61P1/04;A61P9/10;A61P11/00;A61P17/00;A61P19/02;A61P25/00;A61P29/00;A61P31/04;A61P37/06 主分类号 A61K51/00
代理机构 代理人
主权项
地址